Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Press Release

EMBARGOED FOR RELEASE UNTIL 4 PM ET, February 25, 2002

Effective Treatment for Children with ADHD and Chronic Tic Disorders

St. Paul, Minn. -

Research has recently revealed an effective drug therapy for children who have chronic tic disorders (including Tourette''s syndrome) concurrent with attention deficit hyperactivity disorder (ADHD). As many as nine in 10 children with tic disorders also have ADHD. Previously, the use of medications most commonly prescribed to treat children with ADHD had been discouraged for those who also had tic disorders, either because their benefits had not been clinically established or had been associated with a worsening of tics. The stimulant methylphenidate (MPH), also known as Ritalin, has long been the mainstay of treatment for ADHD, with clonidine as the most commonly prescribed alternative. A new study, published in the February 26 Neurology, the scientific journal of the American Academy of Neurology, has demonstrated that both MPH and clonidine, especially when used together, are effective in treating these children, with minimal side effects. "The most effective treatment for ADHD in our trial was the combination of clonidine and MPH," according to study author Roger Kurlan, MD, of the University of Rochester Medical Center in New York. Improvements related to MPH were observed in the areas of "on task" behavior and attentiveness, while improvements related to clonidine included reduced occurrence of crying, frustration, restlessness, excitability and impulsiveness. The 136 study participants, ages seven - 14, were divided into four groups and were administered MPH alone; clonidine alone; MPH and clonidine; and placebo. The placebo group was included as no medication had been previously established to be effective or well-tolerated for treatment of ADHD coupled with chronic tic disorders. Participants'''' responses were measured using ten rating scales, including teacher and parent observation and task and functioning testing, at baseline and every four weeks of the 16-week study. "Not only did tics not worsen during treatment with MPH, the severity of tics actually decreased in all treatment groups," reported Kurlan, "while the benefits of the combined drug therapies were significant in treating ADHD." Moderate sedation, the most common side effect, was related to the use of clonidine.

Brain & Life logo

GET A DOSE OF BRAIN HEALTH

Dive into a wealth of information by visiting Brain & Life®, where you can explore the freshest updates, tips, and neurologist expert perspectives on brain disease and preventive brain health.

DISCOVER MORE


Subscribe to our email newsletter

The American Academy of Neurology is the leading voice in brain health. As the world’s largest association of neurologists and neuroscience professionals with more than 44,000 members, the AAN provides access to the latest news, science and research affecting neurology for patients, caregivers, physicians and professionals alike. The AAN’s mission is to enhance member career fulfillment and promote brain health for all. A neurologist is a doctor who specializes in the diagnosis, care and treatment of brain, spinal cord and nervous system diseases such as Alzheimer's disease, stroke, concussion, epilepsy, Parkinson's disease, multiple sclerosis, headache and migraine.

Explore the latest in neurological disease and brain health, from the minds at the AAN at AAN.com or find us on Facebook, X, LinkedIn, Instagram and YouTube.

For More Information*

Email media@aan.com

*While content of the American Academy of Neurology (AAN) press releases is developed by the AAN along with research authors and Neurology® editors, we are unable to provide medical advice to individuals. Please contact your health care provider for questions specific to your individual health history or care. For more resources, visit the AAN's patient and caregiver website, Brain & Life®.